EORTC-06083-LG

Clofarabine added to prephase and consolidation therapy in acute lymphoblastic leukemia in adults. A prospective randomized trial.
Study documentation
Trial StatusRecruiting
DatesDate of activation: 19-Dec-11
Data management at EORTCMailbox
Phase2-3
Randomized trialYes
TypeHemato-malign
Targeted Sample size-
Number of steps1
DrugMercaptopurine
Tioguanine
Cytarabine
Daunorubicin
Doxorubicin
Etoposide
Leucovorin
Methotrexate
Prednisolone
Prednisone
Vinblastine
Vincristine
Vindesine
Clofarabine
Dexamethasone
Study StaffJean-Pierre Marie (Study Coordinator) - Assistance Publique - Hopitaux de Paris - Hopital Saint Antoine, Paris
Stefan Suciu (Statistician) - EORTC Headquarters, Brussels
Liv Meert (Data Manager) - EORTC Headquarters, Brussels
Safaa Ramadan (Coordinating Physician) - EORTC Headquarters, Brussels
Gaetan de Schaetzen (Project Manager) - EORTC Headquarters, Brussels, gaetan.deschaetzen( at )eortc.be, +32 27741618
Type of cancerAcute Lymphocytic Leukemia
Participating GroupsHemato-Oncologie Volwassenen Nederland(Coordinating Group)
EORTC Leukemia Group
Centers authorized by EORTC
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT2008-005798-36